0000890821
EX-FILING FEES
0000890821
2025-09-29
2025-09-29
0000890821
1
2025-09-29
2025-09-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Tables
FORM
S-3
ENVERIC
BIOSCIENCES, INC.
Table
1: Newly Registered and Carry Forward Securities
| |
Security
Type | |
Security
Class Title | |
Fee
Calculation Rule | |
Amount
Registered(1) | | |
Proposed
Maximum Offering Price Per Unit | |
Maximum
Aggregate Offering Price | | |
Fee
Rate | | |
Amount
of Registration Fee | |
Fees
to Be Paid | |
Equity | |
Common
Stock, par value $0.01 per share | |
Other | |
| 5,019,746 | | |
$0.58
(2) | |
$ | 2,911,452.68 | | |
| 0.00015310 | | |
$ | 445.74 | |
Total
Offering Amounts | |
$ | 2,911,452.68 | | |
| | | |
$ | 445.74 | |
Total
Fees Previously Paid | |
| | | |
| | | |
| — | |
Total
Fees Offsets | |
| | | |
| | | |
| — | |
Net
Fee Due | |
| | | |
| | | |
$ | 445.74 | |
(1) | Pursuant
to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”),
the shares of Common Stock issuable upon the conversion or exercise, as applicable, of the
Warrants offered hereby also include an indeterminate number of additional shares of Common
Stock as may from time to time become issuable by reason of stock splits, stock dividends,
recapitalizations or other similar transactions. |
(2) | With
respect to the shares of Common Stock offered by the Selling Stockholders, estimated at $0.58
per share, the average of the high ($0.60) and low ($0.57) prices as reported on The Nasdaq
Capital Market on September 24, 2025, for the purpose of calculating the registration fee
in accordance with Rule 457(c) under the Securities Act. |
N/A